RBC Capital Maintains Sector Perform on ResMed, Raises Price Target to $244
ResMed Inc.
ResMed Inc. RMD | 0.00 |
RBC Capital analyst Craig Wong-Pan maintains ResMed (NYSE:
RMD) with a Sector Perform and raises the price target from $234 to $244.
